GLP-1 medications work by turning down appetite. For most people, that's the whole point. But if you have a history of an eating disorder — or you're living with one now — "eats less, thinks about food less, loses weight quickly" is not a neutral description. It reads like a list of the exact features you may have worked hard to recover from. So it's reasonable to ask a hard question before you start: is this safe for someone like me? The honest answer is that the evidence is early, genuinely mixed, and points less to a simple yes-or-no than to who needs to be involved in the decision with you.
The genuine concerns
The worry isn't imaginary. GLP-1 medications reduce hunger and increase fullness — for someone with a history of restriction (as in anorexia nervosa or restrictive disordered eating), a medication that makes eating less feel effortless can quietly reinforce the very patterns recovery was meant to interrupt. What looks like a "good response" to the drug — smaller portions, less interest in food, dropping weight — can be hard to tell apart from a relapse dressed in medical clothing.
Rapid weight loss brings its own risk. Losing weight fast can intensify preoccupation with the body, and changes some people notice on a GLP-1 — loose skin, facial thinning — can stir up distress, especially if body image has been a struggle before. If you're not sure whether what you're feeling is normal adjustment or something more, our guide on body-image lag versus body dysmorphia walks through the difference. A history of disordered eating raises the odds that fast change lands hard rather than neutrally.
What the emerging research actually shows
The picture is not all caution, and it's important not to overstate the harm either. Interestingly, the research signal that does exist is mostly on the opposite end of the eating-disorder spectrum: binge eating disorder (BED), the most common eating disorder, which involves recurrent loss-of-control eating rather than restriction.
Based on articles retrieved from PubMed, a 2026 systematic review and meta-analysis found that liraglutide (a GLP-1 medication) reduced binge frequency in binge eating disorder compared with placebo — while stressing that the certainty of evidence was low and the findings are hypothesis-generating, not a green light (DOI (external link)). Two other systematic reviews echo this: early findings suggest GLP-1 medications may reduce binge-eating behavior, but the authors are explicit that large, blinded, placebo-controlled trials are still lacking, so this should not yet be treated as established therapy (DOI (external link), DOI (external link)).
Two honest caveats sit alongside that. First, "may help binge eating" is not the same as "safe for any eating disorder" — the mechanism that could quiet binge urges is the same one that could deepen restriction in someone prone to it. Second, the same psychiatric review that noted BED benefits also flagged reports linking these drugs to depressive symptoms and suicidal ideation in some people; the evidence there is preliminary and inconsistent, but it's a reason for monitoring, not reassurance (DOI (external link)). The research is early on both the promise and the risk.
An active eating disorder is a different situation
There's an important line between history of and currently living with an eating disorder. An active eating disorder — particularly a restrictive one — is generally treated as a caution or contraindication for using a GLP-1 for weight loss. Public-health researchers have specifically called for closer pharmacovigilance of these drugs for misuse and adverse outcomes among high-risk groups, naming people with eating disorders directly, and have warned against framing rapid weight loss itself as the goal (DOI (external link)). Prescribing an appetite suppressant into an active restrictive illness can accelerate harm.
None of this means a history automatically closes the door. It means the framing has to change — away from "how much weight can I lose" and toward whether, and how, treatment fits into an already-established recovery.
This is a decision for a treatment team
The recurring theme across the research is not a verdict but a process: screening before starting, and mental-health involvement during. If you have any eating-disorder history, that history belongs on the table before a prescription is written, and ideally your prescriber and a mental-health professional are talking to each other, not working in silos. Our guide on raising this with a mental-health provider can help you open that conversation and set up check-ins through titration and weight loss. If family members with their own history are part of the picture, talking to them thoughtfully is worth its own care.
The goal of a treatment team is simple: someone who knows your history is watching for the warning signs, so a "good drug response" and a relapse don't get confused.
Warning signs to watch for
During treatment, it's worth flagging any of these to your providers:
- Eating far less than your plan calls for, or skipping meals because "I'm just not hungry" becomes a rule rather than an observation.
- Feeling relief or pride at eating less, or anxiety and guilt when you do eat.
- A pull to lose more weight than is medically recommended, or moving the goalposts each time you hit one.
- Old disordered-eating patterns returning in a new form — rigid rules, food avoidance, compulsive weighing or body-checking.
- Escalating preoccupation with your body, shape, or the number on the scale.
These aren't reasons to feel ashamed or to quietly stop your medication on your own — they're reasons to check in, so the plan can be adjusted with support.
The bottom line
A history of disordered eating doesn't automatically rule out GLP-1 treatment, but it changes what safe looks like: more screening, more monitoring, and a mental-health professional in the loop — not less attention, but more. An active eating disorder, especially a restrictive one, is a different and more serious situation that generally warrants caution before any weight-loss use. The evidence is genuinely early, so treat anyone offering certainty in either direction with suspicion.
Research findings above are attributed to peer-reviewed articles indexed in PubMed. This is general education, not medical or mental-health advice, and it can't tell you whether treatment is right for you — that decision belongs with you and a care team that includes a mental-health professional who knows your history.
If you're struggling with an eating disorder, the National Eating Disorders Association (external link) offers a free screening tool and help resources on its website. If you're in crisis or having thoughts of harming yourself, get help now — in the U.S., call or text 988 (Suicide & Crisis Lifeline), or text HOME to 741741 (Crisis Text Line).